Drug reduces risk of pneumonia in newborn mice

Drug reduces risk of pneumonia in newborn mice

Premature infants are at high risk of developing life-threatening lung infections, partly because their lungs are underdeveloped at birth. A new study from Washington University School of Medicine in St. Louis has found, in mice, that an inhaled drug promotes the development of lung immunity and reduces the risk of pneumonia.

Proposals sought for seed grant program

The newly launched Social Policy Institute and the McDonnell International Scholars Academy are seeking proposals for collaboration between Washington University researchers and researchers at international partner universities.
NIH gives major boost to microbiome research on Medical Campus

NIH gives major boost to microbiome research on Medical Campus

A longtime leader in microbiome research, the School of Medicine plans to expand research into the microbiome with a new mouse facility that will further enable researchers to understand how microbes influence health and disease. The facility will be funded with an $8 million grant from the National Institutes of Health and an additional $2.8 million from the School of Medicine.
Understanding criticality and the brain’s neural networks

Understanding criticality and the brain’s neural networks

New research from Washington University in St. Louis confirms that the brain tunes itself to a point where it is as excitable as it can be without tipping into disorder, similar to a phase transition. The new research from Keith Hengen, assistant professor of biology in Arts & Sciences, is published Oct. 7 in the journal Neuron.
Older Stories